awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34019159-F240EFCF-35D9-4E57-8AFE-A4EDE2BDD925
Q34019159-F240EFCF-35D9-4E57-8AFE-A4EDE2BDD925
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34019159-F240EFCF-35D9-4E57-8AFE-A4EDE2BDD925
Clinical benefit from pemetrexed before and after crizotinib exposure and from crizotinib before and after pemetrexed exposure in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer
P2860
Q34019159-F240EFCF-35D9-4E57-8AFE-A4EDE2BDD925
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34019159-F240EFCF-35D9-4E57-8AFE-A4EDE2BDD925
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43441d6247bfe39f9ac97cb6d2aea9d5701af169
P2860
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.